entacapone

one of the types of COMT inhibitors that is used for the treatment of Parkinson's disease
rdfs:label
"entacapone"@en
skos:altLabel
"(E)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide"@en
"COM998"@en
"N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide"@en
"OR-611"@en
schema:description
"one of the types of COMT inhibitors that is used for the treatment of Parkinson's disease"@en
schema:dateModified "2026-08-14T02:33:40+00:00"^^xsd:dateTime
schema:version 2531128904
wikibase:identifiers 37
wikibase:sitelinks 24
wikibase:statements 66
p:P10245 wd:statement/Q416444-750b2ae5-467f-cfac-1652-e19e347f2221
p:P10283 wd:statement/Q416444-C11334EE-5C1C-433A-BDAB-95EE99DA5BCF
p:P11089 wd:statement/Q416444-9FF6BB58-4AA8-4520-A178-0C39FEDE7E99
p:P11143 wd:statement/Q416444-BD47D22B-5131-49E4-94B1-2E67D872D905
p:P11198 wd:statement/Q416444-A8D2E6DD-0E66-428E-AF68-9C3253706723
p:P11199 wd:statement/Q416444-7A04BB2D-8324-4563-9B1F-B89D9912528C
p:P117 wd:statement/Q416444-2A5B8028-B27A-4429-9B36-E04615319475
p:P129 wd:statement/Q416444-F4A0A2AE-9726-47FD-A3A8-134D81DF83BF
p:P1579 wd:statement/Q416444-84B12B6D-6CA2-461B-9F79-506BA60F6BC7
p:P2017 wd:statement/Q416444-3533C968-06C6-402F-851E-8F8252C96667
p:P2057 wd:statement/Q416444-D8CE5148-8878-414B-BA6B-45ED05BD3EBB
p:P2062 wd:statement/Q416444-EBC93807-9B95-4AA0-B2DE-B56DC4E6137A
p:P2067 wd:statement/Q416444-04C46171-0D25-49B3-B511-CF126E532B7B
p:P2115 wd:statement/Q416444-27BB5332-2DE9-4772-8E3B-482F22970A06
p:P2175 wd:statement/Q416444-3F6D184B-3FEA-4C9A-8419-6CE349657D16
wd:statement/Q416444-A2703DD6-0AEA-43B1-939E-F0CEA8ABE788
p:P2275 wd:statement/Q416444-8C864C37-F2EC-410E-BB8B-59F65F6D449A
p:P231 wd:statement/Q416444-22B4B2A2-1DAC-420F-AA3E-8C4C0B2E5F3D
p:P232 wd:statement/Q416444-5D7753FB-F977-469F-8DAB-20419F18B614
p:P233 wd:statement/Q416444-F2CBE77E-B3A5-4135-B18F-21FCC6CAE7A9
p:P234 wd:statement/Q416444-6C79F999-18F2-4C9E-A019-BFBB0B47D2AF
p:P235 wd:statement/Q416444-6F2F540A-CE55-4CC5-A7DD-3032FFE93C85
p:P2566 wd:statement/Q416444-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q416444-FF8488EC-CF23-4C37-88B5-D782120EC223
p:P274 wd:statement/Q416444-E08E158A-C585-4F99-A26C-98B2DE33B1C4
p:P279 wd:statement/Q416444-DFD33DB6-5D72-4493-88F1-A9A273208A7F
p:P2868 wd:statement/Q416444-30C45FA7-07CD-40CA-ACAA-11FE14252B4D
wd:statement/Q416444-8B3A6ED9-B620-46B4-A961-682A25FCB1AC
wd:statement/Q416444-D78F1EAB-4B26-4355-B39F-1E8114D1F12A
p:P2877 wd:statement/Q416444-8AD8D18B-C3B0-4485-B0BA-FFBDD729755C
p:P2892 wd:statement/Q416444-3B429610-3AAC-44E7-B872-70AAE7F6E6EA
p:P31 wd:statement/Q416444-4CE1D0CF-B952-4E46-9EA1-DBB96CDD9509
p:P3117 wd:statement/Q416444-90FD6E5E-F759-4B84-A357-2BB0A2041B92
p:P3345 wd:statement/Q416444-11E4A5EB-79AA-442E-9EFE-0435B9B17D06
p:P3350 wd:statement/Q416444-c7c90761-4f30-0b33-b48f-1b00dca87498
p:P3489 wd:statement/Q416444-45B837AB-0F5F-4E8E-BBEF-9786CD478F5C
wd:statement/Q416444-BB46B765-1112-450A-B053-734C5142A6C6
p:P3636 wd:statement/Q416444-604C003D-1C00-4CDC-9CC4-613FB61CDFAE
p:P366 wd:statement/Q416444-1927B089-C829-4549-806D-F4EA458DBD62
p:P373 wd:statement/Q416444-04EA2A22-F6B6-42F0-957F-7A8B8F535E45
p:P3780 wd:statement/Q416444-33B316B6-03BB-440C-AD06-1A24EEE99C00
wd:statement/Q416444-5DC4D81D-EB59-4656-8A6B-B0A3EB8DA375
wd:statement/Q416444-7D82925F-AE85-4358-B991-58F739F0CE29
wd:statement/Q416444-E48170C5-4B75-4221-A4A6-1ED00BD8EBFD
p:P4250 wd:statement/Q416444-D449EF6E-4798-4C20-A13A-1C540CD64632
p:P486 wd:statement/Q416444-9B447C90-4211-4A3E-9FA7-11F72F06C463
p:P4964 wd:statement/Q416444-962C97C1-78CE-4A03-AF6A-C905B72C4828
p:P592 wd:statement/Q416444-C4747909-E88D-4068-B227-4F55980ADB65
p:P595 wd:statement/Q416444-49817E2F-A9D7-4940-8ED3-0A32F6CCBCAC
p:P6366 wd:statement/Q416444-9457DFB2-E68A-4430-8D8F-2A135FABFF6E
p:P646 wd:statement/Q416444-2D7E8134-8AF9-4A47-9C04-D7D80CA5C7AD
p:P652 wd:statement/Q416444-02801FB0-8257-4E02-B4A9-29DBDD46877A
p:P661 wd:statement/Q416444-A9AEADED-B4C5-42EE-904C-993D1B51372A
p:P662 wd:statement/Q416444-1324F2AD-7138-498F-B8A2-0F6762DBED65
p:P665 wd:statement/Q416444-DE76D770-03E7-4D74-B4FB-B3ADC8BE9152
wd:statement/Q416444-FFFBA460-039C-4A01-9C25-09DC4C086799
p:P683 wd:statement/Q416444-2782E01B-43FF-44AE-8A0C-8E94995AAAED
p:P715 wd:statement/Q416444-555852A6-DBEA-46A4-8912-AE8AF2EF1928
p:P769 wd:statement/Q416444-449C2731-D743-4267-A4AA-5F6192AA3191
wd:statement/Q416444-91903D32-F4E7-459D-8E3B-764A0AE97CF1
wd:statement/Q416444-E927DAA2-0950-4B1E-A1DE-E7A795E94E11
wd:statement/Q416444-E98D7873-6C2D-48EB-8081-8C8AC9DD5E92
wd:statement/Q416444-FE151449-0DFC-445D-9F99-AE632E227477
p:P7830 wd:statement/Q416444-6EB4131E-D37E-46E8-8104-F6195407D2E9
p:P8026 wd:statement/Q416444-DA0724A3-F6E0-4C45-A5F5-F8B4C12F1077
p:P8494 wd:statement/Q416444-8223D7F2-78E3-421D-A3AD-4850F1705B32
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148629>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C071192>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL953>
p:direct-normalized/P6366 <https://makg.org/entity/2776976799>
p:direct-normalized/P661 <http://rdf.chemspider.com/4444537>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281081>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C07943>
<http://www.kegg.jp/entry/D00781>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_4798>
wdt:P10245 "a601236"
wdt:P10283 "C2776976799"
wdt:P11089 "370219"
wdt:P11143 "Entacapone"
wdt:P11198 "1018"
wdt:P11199 "PD009994"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Entacapon.svg>
wdt:P129 Catechol-O-methyltransferase
wdt:P1579 "8158723"
wdt:P2017 "CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N"
wdt:P2057 "HMDB0012226"
wdt:P2062 "8251"
wdt:P2067 305.101171^^xsd:decimal
wdt:P2115 "N0000148629"
wdt:P2175 Parkinson's disease
wdt:P2275 "entacapone"@en
wdt:P231 "130929-57-6"
wdt:P232 "603-449-6"
wdt:P233 "CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N"
wdt:P234 "InChI=1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+"
wdt:P235 "JRURYQJSLYLRLN-BJMVGYQFSA-N"
wdt:P2566 "100.128.566"
wdt:P267 "N04BX02"
wdt:P274 "C₁₄H₁₅N₃O₅"
wdt:P279 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide
wdt:P2868 antiparkinson
enzyme inhibitor
catechol o-Methyltransferase inhibitors
wdt:P2877 "34504"
wdt:P2892 "C0165921"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID5046439"
wdt:P3345 "60307"
wdt:P3350 "6812"
wdt:P3489 US pregnancy category C
Australian pregnancy category B3
wdt:P3636 "PD9"
wdt:P366 medication
wdt:P373 "Entacapone"
wdt:P3780 Comtan
Comtess
Entacapone Orion
Entacapone Teva
wdt:P4250 1.0^^xsd:decimal
wdt:P486 "C071192"
wdt:P4964 "splash10-0a4i-0329000000-8d20a5650e9c1b1c8275"
wdt:P592 "CHEMBL953"
wdt:P595 "6647"
wdt:P6366 "2776976799"
wdt:P646 "/m/08zfpy"
wdt:P652 "4975G9NM6T"
wdt:P661 "4444537"
wdt:P662 "5281081"
wdt:P665 "C07943"
"D00781"
wdt:P683 "4798"
wdt:P715 "DB00494"
wdt:P769 phenelzine
methyldopa
wdt:P7830 "Entacapone"
wdt:P8026 LiverTox toxicity likelihood category D
wdt:P8494 "DTXCID3026439"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata